Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
2901
DELISTED
Olympic Steel
ZEUS
| $301K | ﹤0.01% |
30,252
-34,778
| -53% | -$440K |
|
|
ALTR
2902
CALL
DELISTED
Altera Corp
ALTR
| $300K | ﹤0.01% |
+6,000
| New | +$298K |
|
2903
Sunstone Hotel Investors
SHO
$2.11B
| $299K | ﹤0.01% |
22,599
-707,372
| -97% | -$10.2M |
|
2904
Crawford & Co Class A
CRD.A
$641M
| $297K | ﹤0.01% |
53,061
-6,574
| -11% | -$43.1K |
|
|
SALM
2905
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $297K | ﹤0.01% |
48,540
-3,587
| -7% | -$21.9K |
|
2906
Ampco-Pittsburgh
AP
$181M
| $296K | ﹤0.01% |
27,167
+14,397
| +113% | +$183K |
|
2907
Northern Oil and Gas
NOG
$2.81B
| $296K | ﹤0.01% |
+6,694
| New | +$343K |
|
2908
Rapid7
RPD
$808M
| $296K | ﹤0.01% |
+13,000
| New | +$289K |
|
|
OMCC
2909
DELISTED
Old Market Capital Corp
OMCC
| $296K | ﹤0.01% |
22,819
+12,222
| +115% | +$159K |
|
|
WRES
2910
DELISTED
WARREN RESOURCES INC
WRES
| $296K | ﹤0.01% |
604,790
-2,361
| -0.4% | -$1.08K |
|
2911
Pitney Bowes
PBI
$2.29B
| $295K | ﹤0.01% |
14,852
-565,070
| -97% | -$11.6M |
|
|
ACGN
2912
DELISTED
Aceragen Inc
ACGN
| $295K | ﹤0.01% |
649
-20
| -3% | -$8.84K |
|
|
FLXN
2913
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $295K | ﹤0.01% |
19,840
+4,154
| +26% | +$97.4K |
|
2914
W&T Offshore
WTI
$552M
| $294K | ﹤0.01% |
+98,010
| New | +$364K |
|
|
FRBK
2915
DELISTED
Republic First Bancorp Inc
FRBK
| $293K | ﹤0.01% |
78,784
+48,949
| +164% | +$176K |
|
2916
Actinium Pharmaceuticals
ATNM
$33.6M
| $292K | ﹤0.01% |
5,501
+75
| +1% | +$5.01K |
|
2917
iShares US Pharmaceuticals ETF
IHE
$1.75B
| $291K | ﹤0.01% |
5,901
-2,055
| -26% | -$118K |
|
2918
Aaon
AAON
$6.34B
| $290K | ﹤0.01% |
+22,413
| New | +$321K |
|
|
ESIO
2919
DELISTED
Electro Scientific Industries
ESIO
| $289K | ﹤0.01% |
62,324
-43,987
| -41% | -$204K |
|
2920
Donegal Group Class A
DGICA
$703M
| $288K | ﹤0.01% |
+20,481
| New | +$296K |
|
|
BITA
2921
DELISTED
Bitauto Holdings Limited
BITA
| $287K | ﹤0.01% |
9,637
-71,444
| -88% | -$2.43M |
|
|
PNX
2922
DELISTED
PHOENIX COMPANIES INC. NEW
PNX
| $287K | ﹤0.01% |
+8,700
| New | +$130K |
|
2923
Invesco Pharmaceuticals ETF
PJP
$535M
| $286K | ﹤0.01% |
+4,306
| New | +$335K |
|
|
NEOS
2924
DELISTED
Neos Therapeutics, Inc
NEOS
| $286K | ﹤0.01% |
+13,628
| New | +$300K |
|
|
FXEN
2925
DELISTED
FX ENERGY INC
FXEN
| $286K | ﹤0.01% |
300,619
-8,070
| -3% | -$7.29K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.